🌪️APPROVATO FARMACO DONANEMAB PER ALZHEIMER
Giorno: 02 luglio 2024 | Ora : 20:36 La FDA degli Stati Uniti ha approvato il farmaco donanemab di Eli Lilly per l'Alzheimer, ampliando le limitate opzioni di trattamento per questa malattia debilitante negli Stati Uniti.
The US FDA has approved Eli Lilly's drug, donanemab, for Alzheimer's, expanding the limited treatment options for this debilitating disease in the United States.
The 🇺🇸 FDA approved Eli Lilly’s $LLY Alzheimer’s drug donanemab, expanding the limited treatment options for the mind-wasting disease in the US - CNBC pic.twitter.com/ypjxjxl47H— Evan (@StockMKTNewz) July 2, 2024
